Literature DB >> 29844009

Workflow and efficiency in MRI-based high-dose-rate brachytherapy for cervical cancer in a high-volume brachytherapy center.

Hayeon Kim1, Christopher J Houser2, Ronny Kalash2, Carly A Maceil2, Brett Palestra2, Deborah Malush2, Sushil Beriwal2.   

Abstract

PURPOSE: We report the clinical workflow and time required for MRI-based image-guided brachytherapy (MR-IGBT) of cervical cancer patients in a high-volume brachytherapy center with 10 years of experiences to provide a practical guideline for implementing MR-IGBT into clinical use. METHODS AND MATERIALS: We recorded the time and workflow of each procedure step within the 40 consecutive ring and tandem applicator fractions of MR-IGBT by our multidisciplinary team. We divided the entire procedure into four sections based on where the procedure was performed: (1) applicator insertion under sedation, (2) MR imaging, (3) planning, and (4) treatment delivery. In addition, we compared the current procedure time to the initial procedure time when first implementing MR-IGBT in 2007-2008 via a retrospective review.
RESULTS: Mean total procedure time was 149.3 min (SD 17.9, ranges 112-178). The multidisciplinary team included an anesthesia team, radiologist, radiation oncologist, nurses, radiation therapists, MRI technicians, dosimetrists, and physicists. The mean procedure time and ranges for each section (min) were as follows: (1) 56.2 (28.0-103.0), (2) 31.0 (19.0-70.0), (3) 44.3 (21.0-104.0), and (4) 17.8 (9.0-34.0). Under current setting, the combined mean procedure time for MR imaging and planning was 63.2 min. In comparison, the same procedure took 137.7 min in 2007-2008 period, which was significantly longer than the current workflow (p < 0.001).
CONCLUSIONS: A skilled and dedicated multidisciplinary team is required for an efficient clinical workflow and delivery of MR-IGBT. Over the years, we have improved efficiency with clinical experience and continuous efforts in staff education.
Copyright © 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Efficiency; HDR brachytherapy; MR-IGBT; Workflow

Mesh:

Year:  2018        PMID: 29844009     DOI: 10.1016/j.brachy.2018.05.001

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  5 in total

1.  MR-Tracked Deflectable Stylet for Gynecologic Brachytherapy.

Authors:  Anthony L Gunderman; Ehud J Schmidt; Marc Morcos; Junichi Tokuda; Ravi T Seethamraju; Henry R Halperin; Akila N Viswanathan; Yue Chen
Journal:  IEEE ASME Trans Mechatron       Date:  2021-03-09       Impact factor: 5.303

2.  Development of a workflow process mapping protocol to inform the implementation of regional patient navigation programs in breast oncology.

Authors:  Nicole L Casanova; Amy M LeClair; Victoria Xiao; Katelyn R Mullikin; Stephenie C Lemon; Karen M Freund; Jennifer S Haas; Rachel A Freedman; Tracy A Battaglia
Journal:  Cancer       Date:  2022-07-01       Impact factor: 6.921

3.  Clinical Implication of Simultaneous Intensity-modulated Radiotherapy Boost to Tumor Bed for Cervical Cancer with Full-thickness Stromal Invasion.

Authors:  Zongkai Zhang; Long Jiang; Rui Bi; Xiaohua Wu; Jun Zhu; Guihao Ke
Journal:  Oncologist       Date:  2022-02-03

Review 4.  Dose Summation Strategies for External Beam Radiation Therapy and Brachytherapy in Gynecologic Malignancy: A Review from the NRG Oncology and NCTN Medical Physics Subcommittees.

Authors:  Hayeon Kim; Yongsook C Lee; Stanley H Benedict; Brandon Dyer; Michael Price; Yi Rong; Ananth Ravi; Eric Leung; Sushil Beriwal; Mark E Bernard; Jyoti Mayadev; Jessica R L Leif; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-06-17       Impact factor: 7.038

5.  Analysis of Applicator Insertion Related Acute Side Effects for Cervical Cancer Treated With Brachytherapy.

Authors:  Jiajun Chen; Ning Zhang; Ying Liu; Dongmei Han; Zhuang Mao; Wei Yang; Guanghui Cheng
Journal:  Front Oncol       Date:  2021-06-07       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.